Zenoaq

Manufacturing · California, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

23591 El Toro Rd Ste 180, Lake Forest, C...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1

About Zenoaq

Established in 1946, Zenoaq is a leading animal health company in Japan. With a workforce of nearly 700 employees and the generation of 24.2 billion in sales (approximately US$195 million) in the 2014 fiscal year, Zenoaq has a solid business model focused on R&D, manufacturing and importation of animal health products, contributing to a broad product portfolio for production and companion animals. In addition, Zenoaq, headquartered in Fukushima, has the widest distribution network for veterinary products in Japan, supported by a strong direct sales force. In June 2014, Zenoaq launched Allermmune HDM, a first-of-its-kind desensitization therapy for house dust mite-induced canine atopic dermatitis, reflecting the company's increased focus on an innovative pipeline for the companion animal market. Zenoaq's partners include Merial, Mars, Intervet, DSM Nutrition as well as IDEXX Laboratories.Explore more
Zenoaq's Social MediaPopular SearchesZenoaqNippon Zenyaku Kogyo Co. LtdNippon Zenyaku Kogyo Co LtdZenoaq Resource Co LtdZenyakuSIC Code 28,283NAICS Code 32,325Show more

Zenoaq Org Chart

PhoneEmail
JS
United States flag for contact location.

Division Director, Supply Chain

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Zenoaq your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Zenoaq is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Zenoaq is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Zenoaq.

Zenoaq Tech Stack

Zenoaq News & Media

  • Immunomic Therapeutics Licenses Investigational Canine Dermatitis Therapy to ZENOAQ

    ROCKVILLE, Md.--(BUSINESS WIRE)--#allergies--Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company has granted Japanese animal health company, ZENOAQ (Nippon Zenyaku Kogyo Co., Ltd, Koriyama, Japan) an exclusive license to develop and commercialize its investigational DNA vaccine, ITI-002, for canine atopic dermatitis and other companion animal allergies. The therapy was developed using ITI’s proprietary UNITE™ (UNiversal Int
Read more news

Top Manufacturing Companies

Frequently Asked Questions Regarding Zenoaq

What is Zenoaq's official website?
Zenoaq's official website is www.zenoaq.jp
What is Zenoaq's Revenue?
Zenoaq's revenue is <$5 Million
What is Zenoaq's SIC code?
Zenoaq's SIC: 28,283
What is Zenoaq's NAICS code?
Zenoaq's NAICS: 32,325
How many employees does Zenoaq have?
Zenoaq has 11-50 employees
What industry does Zenoaq belong to?
Zenoaq is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What technology does Zenoaq use?
Some of the popular technologies that Zenoaq uses are: Microsoft 365, Piped Bits SPIRAL, Symantec Email Security, Microsoft Exchange Online
What does Zenoaq do?

Established in 1946, Zenoaq is a leading animal health company in Japan. With a workforce of nearly 700 employees and the generation of 24.2 billion in sales (approximately US$195 million) in the 2014 fiscal year, Zenoaq has a solid business model focused on R&D, manufacturing and importation of animal health products, contributing to a broad produ... ct portfolio for production and companion animals. In addition, Zenoaq, headquartered in Fukushima, has the widest distribution network for veterinary products in Japan, supported by a strong direct sales force. In June 2014, Zenoaq launched Allermmune HDM, a first-of-its-kind desensitization therapy for house dust mite-induced canine atopic dermatitis, reflecting the company's increased focus on an innovative pipeline for the companion animal market. Zenoaq's partners include Merial, Mars, Intervet, DSM Nutrition as well as IDEXX Laboratories.Read More

What are Zenoaq social media links?
Zenoaq Facebook page
Is Zenoaq a public company?
Zenoaq is private company therefore does not currently have an official ticker symbol
See more information about Zenoaq

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.